vs

Side-by-side financial comparison of INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $66.7M, roughly 1.9× INNOVATIVE INDUSTRIAL PROPERTIES INC). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -13.1%). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs -6.0%).

Oxford Properties is a Canadian multinational corporation, with operations in real estate investment, development and property management. Its portfolio includes office, retail, industrial, multi-residential, life sciences and hotel assets. Established privately in 1960 and later wholly owned by the Ontario Municipal Employees Retirement System (OMERS) since 2003, the company is headquartered in Toronto with regional head offices in New York City, London, Australia, Singapore and Luxembourg. ...

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

IIPR vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.9× larger
ZLAB
$127.1M
$66.7M
IIPR
Growing faster (revenue YoY)
ZLAB
ZLAB
+30.3% gap
ZLAB
17.1%
-13.1%
IIPR
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
-6.0%
IIPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IIPR
IIPR
ZLAB
ZLAB
Revenue
$66.7M
$127.1M
Net Profit
$31.8M
Gross Margin
51.0%
Operating Margin
47.8%
-54.6%
Net Margin
47.8%
Revenue YoY
-13.1%
17.1%
Net Profit YoY
-20.4%
EPS (diluted)
$1.07
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$66.7M
$127.1M
Q3 25
$64.7M
$115.4M
Q2 25
$62.9M
$109.1M
Q1 25
$71.7M
$105.7M
Q4 24
$76.7M
$108.5M
Q3 24
$76.5M
$101.8M
Q2 24
$79.8M
$100.1M
Q1 24
$75.5M
$87.1M
Net Profit
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$31.8M
Q3 25
$29.3M
$-36.0M
Q2 25
$26.0M
$-40.7M
Q1 25
$31.1M
$-48.4M
Q4 24
$40.0M
Q3 24
$40.2M
$-41.7M
Q2 24
$42.0M
$-80.3M
Q1 24
$39.4M
$-53.5M
Gross Margin
IIPR
IIPR
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Q1 24
61.4%
Operating Margin
IIPR
IIPR
ZLAB
ZLAB
Q4 25
47.8%
-54.6%
Q3 25
45.5%
-42.3%
Q2 25
45.9%
-50.3%
Q1 25
47.4%
-53.3%
Q4 24
54.7%
-62.6%
Q3 24
54.8%
-66.6%
Q2 24
53.1%
-76.0%
Q1 24
55.7%
-80.7%
Net Margin
IIPR
IIPR
ZLAB
ZLAB
Q4 25
47.8%
Q3 25
45.3%
-31.2%
Q2 25
41.4%
-37.3%
Q1 25
43.3%
-45.8%
Q4 24
52.2%
Q3 24
52.6%
-40.9%
Q2 24
52.6%
-80.2%
Q1 24
52.3%
-61.4%
EPS (diluted)
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$1.07
$-0.05
Q3 25
$0.97
$-0.03
Q2 25
$0.86
$-0.04
Q1 25
$1.03
$-0.04
Q4 24
$1.35
$-0.09
Q3 24
$1.37
$-0.04
Q2 24
$1.44
$-0.08
Q1 24
$1.36
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIPR
IIPR
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$47.6M
$689.6M
Total DebtLower is stronger
$393.7M
Stockholders' EquityBook value
$1.8B
$715.5M
Total Assets
$2.4B
$1.2B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$47.6M
$689.6M
Q3 25
$41.9M
$717.2M
Q2 25
$104.9M
$732.2M
Q1 25
$133.3M
$757.3M
Q4 24
$151.2M
$779.7M
Q3 24
$172.4M
$616.1M
Q2 24
$160.9M
$630.0M
Q1 24
$173.5M
$650.8M
Total Debt
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$393.7M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$1.8B
$715.5M
Q3 25
$1.9B
$759.9M
Q2 25
$1.9B
$791.7M
Q1 25
$1.9B
$810.8M
Q4 24
$1.9B
$840.9M
Q3 24
$1.9B
$667.7M
Q2 24
$1.9B
$704.2M
Q1 24
$2.0B
$762.2M
Total Assets
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$2.4B
$1.2B
Q3 25
$2.3B
$1.2B
Q2 25
$2.3B
$1.2B
Q1 25
$2.4B
$1.2B
Q4 24
$2.4B
$1.2B
Q3 24
$2.4B
$985.3M
Q2 24
$2.4B
$987.4M
Q1 24
$2.4B
$988.4M
Debt / Equity
IIPR
IIPR
ZLAB
ZLAB
Q4 25
0.21×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIPR
IIPR
ZLAB
ZLAB
Operating Cash FlowLast quarter
$198.2M
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
6.22×
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$198.2M
$-26.0M
Q3 25
$45.6M
$-32.0M
Q2 25
$48.4M
$-31.0M
Q1 25
$54.2M
$-61.7M
Q4 24
$258.4M
$-55.8M
Q3 24
$64.9M
$-26.8M
Q2 24
$64.2M
$-42.2M
Q1 24
$71.6M
$-90.1M
Free Cash Flow
IIPR
IIPR
ZLAB
ZLAB
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-63.2M
Q4 24
$-58.4M
Q3 24
$-28.2M
Q2 24
$-42.9M
Q1 24
$-91.1M
FCF Margin
IIPR
IIPR
ZLAB
ZLAB
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-59.9%
Q4 24
-53.8%
Q3 24
-27.7%
Q2 24
-42.9%
Q1 24
-104.5%
Capex Intensity
IIPR
IIPR
ZLAB
ZLAB
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.5%
Q4 24
2.4%
Q3 24
1.3%
Q2 24
0.7%
Q1 24
1.1%
Cash Conversion
IIPR
IIPR
ZLAB
ZLAB
Q4 25
6.22×
Q3 25
1.56×
Q2 25
1.86×
Q1 25
1.75×
Q4 24
6.46×
Q3 24
1.61×
Q2 24
1.53×
Q1 24
1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIPR
IIPR

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons